1.
Gan To Kagaku Ryoho
; 33(3): 365-7, 2006 Mar.
Artigo
em Japonês
| MEDLINE
| ID: mdl-16531720
RESUMO
A 35-year-old woman with taxane and anthracycline-resistant recurrent breast cancer with multiple lung metastasis and carcinomatous lymphangitis was treated with CMF as third-line chemotherapy. A complete response was achieved,and the toxicities were tolerable. We thought that CMF could be a useful regimen as third-line chemotherapy for metastatic breast cancer.